NCT06969170: Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder
- State
- Under way
- Phase
- Phase 2
- People
- 50 planned
- Started
- 16 May 2025
- Primary completion
- 31 Dec 2027
- Arms
- Psilocybin Oral Solution
- Results
- None posted
- 13 May 2025: Trial registered
- 16 May 2025: Trial started